CoChat

Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population

Huang, Mengmeng, Jiao, Jingjing, Zhuang, Pan, Chen, Xinyu, Wang, Jun, Zhang, Yu · 2018 · Environment International
Cited by 174

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND Perfluoroalkyl chemicals (PFCs) as possible cardiovascular disrupters are universally detected in humans. However, evidence from epidemiological studies appears insufficient and ambiguous. OBJECTIVES We aim to examine the serum PFCs levels and their associations with the prevalence of cardiovascular diseases (CVD) and related outcomes in general US population. METHODS We investigated the serum levels of 12 major PFCs, including perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), perfluorohexane sulfonic acid (PFHxS), 2-(N-ethyl-perfluorooctane sulfonamido) acetate (EPAH), 2-(N-methyl-perfluorooctane sulfonamido) acetate (MPAH), perfluorodecanoic acid (PFDE), perfluorobutane sulfonate (PFBS), perfluoroheptanoic acid (PFHP), perfluorononanoic acid (PFNA), perfluorooctane sulfonamide (PFSA), perfluoroundecanoic acid (PFUA), and perfluorododecanoic acid (PFDO), in 10,859 participants from the National Health and Nutritional Examination Survey (NHANES) 1999-2014. Logistic regression models were used to estimate the associations between serum PFCs and 5 self-reported CVD outcomes, including congestive heart failure, coronary heart disease, angina pectoris, heart attack, and stroke. Linear regression analyses were used to estimate the PFCs and their associations with 8 traditional CVD risk factors like serum triglyceride and total cholesterol. RESULTS In multivariable-adjusted models, total PFCs were positively associated with total CVD (p for trend = 0.0166), independent of traditional CVD risk factors, such as smoking status, diabetes, hypertension and serum cholesterol level. Compared with reference quartile of total PFCs levels, the multivariable adjusted odds ratios in increasing quartiles were 1.23 [95% confidence interval (CI): 0.91-1.66], 1.47 (95% CI: 1.14-1.89) and 1.45 (95% CI: 1.06-1.98) for total CVD. Similar positive associations were found if considering individual PFCs including PFOS, PFUA, MPAH, EPAH, PFDO, PFSA and PFBS. In addition, serum levels of MPAH and PFDO were positively associated with congestive heart failure; PFNA, PFDE, and PFUA were positively associated with coronary heart disease; PFUA and PFDO were positively associated with angina pectoris; and PFNA was positively associated with heart attack. CONCLUSIONS Our findings suggested that exposure to PFCs was positively associated with risk of CVD. Further longitudinal studies are needed to increase our understanding about the role of PFCs exposure in the prevalence of CVD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.envint.2018.05.051

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 49

  1. Ajith, 2016, Peroxisome proliferator-activated receptors in cardiac energy metabolism and cardiovascular disease, Clin. Exp. Pharmacol. Physiol., 43, 649, 10.1111/1440-1681.12579 · DOI
  2. Baccarelli, 2010, Ischemic heart disease and stroke in relation to blood DNA methylation, Epidemiology, 21, 819, 10.1097/EDE.0b013e3181f20457 · DOI · Paper page
  3. Barger, 2000, PPAR signaling in the control of cardiac energy metabolism, Trends Cardiovasc. Med., 10, 238, 10.1016/S1050-1738(00)00077-3 · DOI · Paper page
  4. Bhatnagar, 2006, Environmental cardiology - studying mechanistic links between pollution and heart disease, Circ. Res., 99, 692, 10.1161/01.RES.0000243586.99701.cf · DOI · Paper page
  5. Butenhoff, 2004, Characterization of risk for general population exposure to perfluorooctanoate, Regul. Toxicol. Pharmacol., 39, 363, 10.1016/j.yrtph.2004.03.003 · DOI
  6. Cash, 2011, Cardiovascular disease risk factors and DNA methylation at the LINE-1 repeat region in peripheral blood from Samoan Islanders, Epigenetics., 6, 1257, 10.4161/epi.6.10.17728 · DOI
  7. Chang, 2016, A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans, Crit. Rev. Toxicol., 46, 279, 10.3109/10408444.2015.1122573 · DOI · Paper page
  8. Chobanian, 2003, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report, JAMA, 289, 2560, 10.1001/jama.289.19.2560 · DOI · Paper page
  9. Coperchini, 2015, Exposure to perfluorinated compounds: in vitro study on thyroid cells, Environ. Sci. Pollut. Res. Int., 22, 2287, 10.1007/s11356-014-3480-9 · DOI
  10. De Silva, 2012, Phosphorus-containing fluorinated organics: polyfluoroalkyl phosphoric acid diesters (diPAPs), perfluorophosphonates (PFPAs), and perfluorophosphinates (PFPIAs) in residential indoor dust, Environ. Sci. Technol., 46, 12575, 10.1021/es303172p · DOI · Paper page
  11. Dong, 2016, Hepatic miRNA profiles and thyroid hormone homeostasis in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS), Environ. Toxicol. Pharmacol., 41, 201, 10.1016/j.etap.2015.12.009 · DOI
  12. Feig, 2008, Uric acid and cardiovascular risk, N. Engl. J. Med., 359, 1811, 10.1056/NEJMra0800885 · DOI · Paper page
  13. Finck, 2007, The PPAR regulatory system in cardiac physiology and disease, Cardiovasc. Res., 73, 269, 10.1016/j.cardiores.2006.08.023 · DOI · Paper page
  14. Fromme, 2009, Perfluorinated compounds–exposure assessment for the general population in Western countries, Int. J. Hyg. Environ. Health, 212, 239, 10.1016/j.ijheh.2008.04.007 · DOI · Paper page
  15. Geiger, 2013, Positive association between perfluoroalkyl chemicals and hyperuricemia in children, Am. J. Epidemiol., 177, 1255, 10.1093/aje/kws392 · DOI · Paper page
  16. Geiger, 2014, The association between PFOA, PFOS and serum lipid levels in adolescents, Chemosphere, 98, 78, 10.1016/j.chemosphere.2013.10.005 · DOI · Paper page
  17. Glantzounis, 2005, Uric acid and oxidative stress, Curr. Pharm. Des., 11, 4145, 10.2174/138161205774913255 · DOI · Paper page
  18. Gutshall, 1989, Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats, J. Toxicol. Environ. Health, 28, 53, 10.1080/15287398909531328 · DOI · Paper page
  19. Haug, 2009, Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples, Environ. Sci. Technol., 43, 2131, 10.1021/es802827u · DOI · Paper page
  20. Haug, 2010, Diet and particularly seafood are major sources of perfluorinated compounds in humans, Environ. Int., 36, 772, 10.1016/j.envint.2010.05.016 · DOI · Paper page
  21. International Agency for Research on Cancer (IARC), 2015, Perfluoro-octanoic acid, tetrafluoroethylene, dichloromethane,1,2-dichloropropane, and 1,3-propane sultone, IARC Monogr. Eval. Carcinog. Risk Chem. Hum., 110
  22. Jiang, 2011, Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy, Adv. Exp. Med. Biol., 721, 19, 10.1007/978-1-4614-0650-1_2 · DOI
  23. Jin, 2015, Isomer profiles of perfluoroalkyl substances in water and soil surrounding a Chinese fluorochemical manufacturing park, Environ. Sci. Technol., 49, 4946, 10.1021/acs.est.5b00212 · DOI · Paper page
  24. Klaunig, 2012, Mode of action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and human relevance, Reprod. Toxicol., 33, 410, 10.1016/j.reprotox.2011.10.014 · DOI
  25. Lin, 2009, Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults, Diabetes Care, 32, 702, 10.2337/dc08-1816 · DOI · Paper page
  26. Liu, 2018, Association among total serum isomers of perfluorinated chemicals, glucose homeostasis, lipid profiles, serum protein and metabolic syndrome in adults: NHANES, 2013–2014, Environ. Pollut., 232, 73, 10.1016/j.envpol.2017.09.019 · DOI
  27. Mastin, 2005, Environmental cardiovascular disease, Cardiovasc. Toxicol., 5, 91, 10.1385/CT:5:2:091 · DOI
  28. Matilla-Santander, 2017, Exposure to Perfluoroalkyl substances and metabolic outcomes in pregnant women: evidence from the Spanish INMA Birth Cohorts, Environ. Health Perspect., 125, 10.1289/EHP1062 · DOI · Paper page
  29. Mattsson, 2015, Levels of perfluoroalkyl substances and risk of coronary heart disease: findings from a population-based longitudinal study, Environ. Res., 142, 148, 10.1016/j.envres.2015.06.033 · DOI
  30. Miralles-Marco, 2015, Perfluorooctane sulfonate: a review of human exposure, biomonitoring and the environmental forensics utility of its chirality and isomer distribution, Environ. Int., 77, 148, 10.1016/j.envint.2015.02.002 · DOI · Paper page
  31. Nakatochi, 2017, Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease, Clin. Epigenetics, 9, 54, 10.1186/s13148-017-0353-3 · DOI
  32. Okada, 2013, Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003–2011, Environ. Int., 60, 89, 10.1016/j.envint.2013.07.013 · DOI
  33. Olsen, 2009, Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives, Reprod. Toxicol., 27, 212, 10.1016/j.reprotox.2009.02.001 · DOI · Paper page
  34. Prevedouros, 2006, Sources, fate and transport of perfluorocarboxylates, Environ. Sci. Technol., 40, 32, 10.1021/es0512475 · DOI · Paper page
  35. Roth, 2015, Global and regional patterns in cardiovascular mortality from 1990 to 2013, Circulation, 132, 1667, 10.1161/CIRCULATIONAHA.114.008720 · DOI · Paper page
  36. Seacat, 2003, Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats, Toxicology, 183, 117, 10.1016/S0300-483X(02)00511-5 · DOI · Paper page
  37. Selvin, 2007, Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988–1994, 1999–2004, Am. J. Kidney Dis., 50, 918, 10.1053/j.ajkd.2007.08.020 · DOI · Paper page
  38. Seo, 2018, Influence of exposure to perfluoroalkyl substances (PFASs) on the Korean general population: 10-year trend and health effects, Environ. Int., 113, 149, 10.1016/j.envint.2018.01.025 · DOI · Paper page
  39. Shankar, 2011, Perfluoroalkyl chemicals and elevated serum uric acid in US adults, J. Clin. Epidemiol., 3, 251, 10.2147/CLEP.S21677 · DOI · Paper page
  40. Shankar, 2012, Perfluorooctanoic acid and cardiovascular disease in US adults, Arch. Intern. Med., 172, 1397, 10.1001/archinternmed.2012.3393 · DOI · Paper page
  41. Toms, 2014, Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011, Environ. Int., 71, 74, 10.1016/j.envint.2014.05.019 · DOI · Paper page
  42. Watkins, 2014, Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation, Environ. Int., 63, 71, 10.1016/j.envint.2013.10.018 · DOI · Paper page
  43. White, 2011, Endocrine disrupting properties of perfluorooctanoic acid, J. Steroid Biochem. Mol. Biol., 127, 16, 10.1016/j.jsbmb.2011.03.011 · DOI · Paper page
  44. Wolf, 2008, Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths, Toxicol. Sci., 106, 162, 10.1093/toxsci/kfn166 · DOI · Paper page
  45. Xie, 2013, Industrial source identification and emission estimation of perfluorooctane sulfonate in China, Environ. Int., 52, 1, 10.1016/j.envint.2012.11.004 · DOI · Paper page
  46. Yanovski, 2011, Obesity prevalence in the United States–up, down, or sideways?, N. Engl. J. Med., 364, 987, 10.1056/NEJMp1009229 · DOI · Paper page
  47. Yeung, 2013, Part I. A temporal study of PFCAs and their precursors in human plasma from two German cities 1982–2009, Environ. Sci. Technol., 47, 3865, 10.1021/es303716k · DOI · Paper page
  48. Yu, 2009, Prenatal and postnatal impact of perfluorooctane sulfonate (PFOS) on rat development: a cross-foster study on chemical burden and thyroid hormone system, Environ. Sci. Technol., 43, 8416, 10.1021/es901602d · DOI · Paper page
  49. Zhang, 2010, Perfluorinated compounds in whole blood samples from infants, children, and adults in China, Environ. Sci. Technol., 44, 4341, 10.1021/es1002132 · DOI · Paper page

Cited by

See all 174

Metadata

Authors
Huang, M., Jiao, J., Zhuang, P., Chen, X., Wang, J., & Zhang, Y.
Venue
Environment International
Publisher
Elsevier BV
Published
2018-10
Volume
119
Pages
37-46
ISSN
0160-4120 (ISSN-L)
OpenAlex
W2808756851
Cited by
174
References
12
FWCI
6.76
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Key Research and Development Program of China (2017YFC1600500)
  • China National Program for Support of Top-notch Young Professionals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population. https://app.cochat.ai/papers/10.1016/j.envint.2018.05.051
The paper
Huang, M., Jiao, J., Zhuang, P., Chen, X., Wang, J., & Zhang, Y. (2018). Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population. Environment International. https://doi.org/10.1016/j.envint.2018.05.051

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.